Bromantane

Structural formula
General
Surname	Bromantane
other names	N - (4-bromophenyl) tricyclo [3.3.1.1 3.7 ] -decan-2-amine ( IUPAC ) Adamantylbromophenylamine
Molecular formula	C 16 H 20 BrN
External identifiers / databases
CAS number 87913-26-6 EC number 687-739-8 ECHA InfoCard 100.213.907 PubChem 4660557 Wikidata Q385533
properties
Molar mass	306.2 g · mol -1
safety instructions
GHS labeling of hazardous substances Caution H and P phrases H: 315-319-335 P: ?
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

Bromantan , even Bromontan as Bemantan an amantadine - derivative . It increases the performance of the muscle and is used as a psychostimulant and immune stimulant . Bromantane was developed in Russia and is on the doping list .

doping

Bromantane became known during the Olympic Games in Atlanta (1996). At that time, five athletes were disqualified for using bromantane. The disqualifications had to be lifted later because not enough facts were known about the effects of Bromantane at the time. Meanwhile, the psychostimulating effect is considered proven. In addition, it can be assumed that bromantane can mask the use of erythropoietin . Like Carphedon, bromantane was very likely developed for use in the military and in sports.

Individual evidence

1. ↑ There is not yet a harmonized classification for this substance . A labeling of N- (2-adamantyl) -N- (2-p-bromophenyl) amine in the Classification and Labeling Inventory of the European Chemicals Agency (ECHA), accessed on June 22, 2019, is reproduced from a self-classification by the distributor .
2. ↑ Burnat, P. et al. (1997): Bromontan, a new doping agent. In: Lancet. Vol. 350, pp. 963-964, PMID 9314900 .

This article is about a health issue. It is not used for self-diagnosis and does not replace a diagnosis by a doctor. Please note the information on health issues !